Picardi, Vincenzo; Deodato, Francesco; Guido, Alessandra; Giaccherini, Lucia; Macchia, Gabriella; Frazzoni, Leonardo; Farioli, Andrea; Cuicchi, Dajana; Cilla, Savino; Cellini, Francesco; Uddin, A.F.M. Kamal; Gambacorta, Maria Antonietta; Buwenge, Milly; Ardizzoni, Andrea; Poggioli, Gilberto; Valentini, Vincenzo; Fuccio, Lorenzo; Morganti, Alessio G., Palliative Short-Course Radiation Therapy in Rectal Cancer: A Phase 2 Study, «INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS», 2016, 95, pp. 1184 - 1190 [articolo]
van Kruijsdijk, R. C. M.; Visseren, F. L. J; Boni, L.; Groen, H. J. M.; Dingemans, A. M. C.; Aerts, J. G. J. V.; van der Graaf, Y.; Ardizzoni, Andrea; Smit, E. F., Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: Treating the right patients based on individualized treatment effect prediction, «ANNALS OF ONCOLOGY», 2016, 27, Article number: mdw154, pp. 1280 - 1286 [articolo]
Gelsomino, Francesco; Ambrosini, Valentina; Melotti, Barbara; Sperandi, Francesca; Ardizzoni, Andrea, Pitfalls in oncology: Osteoblastic response mimicking bone progression during ceritinib treatment in ALK-rearranged NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2016, 11, pp. e99 - e101 [articolo]
Ardizzoni, Andrea; Tiseo, Marcello; Boni, Luca; Di Maio, Massimo; Buffoni, Lucio; Belvedere, Ornella; Grossi, Francesco; D'Alessandro, Vito; de Marinis, Filippo; Barbera, Santi; Caroti, Cinzia; Favaretto, Adolfo; Cortinovis, Diego; Morrica, Brunello; Tixi, Lucia; Ceschia, Tino; Parisi, Salvatore; Ricardi, Umberto; Grimaldi, Andrea; Loreggian, Lucio; Navarria, Pierina; Huber, Rudolf M.; Belani, Chandra; Bruswig, Paal Fr; Scagliotti, Giorgio Vittorio; Scolaro, Tindaro, Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC, «LUNG CANCER», 2016, 100, pp. 30 - 37 [articolo]
Ciccarese C.; Di Nunno V.; Montironi R.; Fiorentino M.; Brunelli M.; Tortora G.; Ardizzoni A.; Massari F., The role of precision medicine for the treatment of metastatic renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2016, 1, pp. 369 - 377 [articolo]
Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano, 11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2016, 43, pp. 1971 - 1979 [articolo]
Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocilla, E; Ardizzoni, A; Fanti, S, 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2016, 43, pp. 84 - 91 [articolo]
G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti, 18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results, in: Supplement, Heidelberg, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2016, 43, pp. 305 - 305 (atti di: European Association of Nuclear Medicine, Barcelona, 20 Ottobre 2016) [atti di convegno-abstract]
Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranzano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio, Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study, «LUNG CANCER», 2015, 90, pp. 234 - 242 [articolo]
Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Z.; Morabito, Alessandro; Min, Young J.; Ardizzoni, Andrea; Gadgeel, Shirish M.; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D., Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): An open-label randomised controlled phase 3 trial, «THE LANCET ONCOLOGY», 2015, 16, pp. 897 - 907 [articolo]
Bozzetti, Cecilia; Nizzoli, Rita; Tiseo, Marcello; Squadrilli, Anna; Lagrasta, Costanza; Buti, Sebastiano; Gasparro, Donatello; Zanoni, Daniele; Majori, Maria; De Filippo, Massimo; Mazzoni, Francesca; Maddau, Cristina; Naldi, Nadia; Sammarelli, Gabriella; Frati, Caterina; Pinto, Carmine; Ardizzoni, Andrea, ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients, «DIAGNOSTIC CYTOPATHOLOGY», 2015, 43, pp. 941 - 946 [articolo]
Facchinetti, Francesco; Aldigeri, Raffaella; Aloe, Rosalia; Bortesi, Beatrice; Ardizzoni, Andrea; Tiseo, Marcello, CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients, «TUMOR BIOLOGY», 2015, 36, pp. 5943 - 5951 [articolo]
Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Tiseo, Marcello; Ardizzoni, Andrea; Alfieri, Roberta R., Effect of ABCG2/BCRP expression on efflux and uptake of Gefitinib in NSCLC cell lines, «PLOS ONE», 2015, 10, Article number: e0141795, pp. 1 - 18 [articolo]Open Access
Bordi, Paola; Tiseo, Marcello; Buti, Sebastiano; Regolisti, Giuseppe; Ardizzoni, Andrea, Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH, «TUMORI», 2015, 101, pp. e51 - e53 [articolo]
Negri, Francesca V; Dal Bello, Barbara; Porta, Camillo; Campanini, Nicoletta; Rossi, Sandro; Tinelli, Carmine; Poggi, Guido; Missale, Gabriele; Fanello, Silvia; Salvagni, Stefania; Ardizzoni, Andrea; Maria, Silini Enrico, Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment, «LIVER INTERNATIONAL», 2015, 35, pp. 2001 - 2008 [articolo]
